TNF-alpha inhibitors: Adalimumab (Humira) Certolizumab pegol (Cimzia) Etanercept (Enbrel) Infliximab (Remicade) IL-23 inhibitors: Guselkumab (Tremfya) Tildrakizumab (Ilumya) Risankizumab (Skyrizi) IL-17A inhibitors: Ixekizumab (Taltz) Secukinumab (Cosentyx) IL-12/IL-23 inhibitors: Ustekinumab (Stelara) IL-17RA inhibitors: Brodalumab (Siliq) Biologics, also known as biologic therapies, are a class of medications that are designed to target specific molecules or cells within the immune system in order to treat various diseases, including psoriasis. There are several different types of biologics available, each of which works by targeting a different part of the immune system. TNF-alpha inhibitors are a class of biologics that target the protein TNF-alpha (tumor necrosis factor-alpha). TNF-alpha is a pro-inflammatory cytokine that is involved in the development of psoriasis and other autoimmune diseases. By binding to and neutralizing TNF-alpha, TNF-alpha inhibitors are able to redu...
Patient information resource on dermatological conditions and skin care